These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21881296)

  • 1. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle.
    Shimura T
    J Radiat Res; 2011; 52(5):539-44. PubMed ID: 21881296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
    Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
    Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
    Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy.
    Shimura T
    Int J Radiat Biol; 2017 Apr; 93(4):381-385. PubMed ID: 27910734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
    Shimura T; Ochiai Y; Noma N; Oikawa T; Sano Y; Fukumoto M
    Cell Cycle; 2013 Mar; 12(5):773-82. PubMed ID: 23388457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin induces G
    Chen MJ; Cheng AC; Lee MF; Hsu YC
    J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
    Ong CS; Zhou J; Ong CN; Shen HM
    Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
    Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
    Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
    Yu XJ; Han QB; Wen ZS; Ma L; Gao J; Zhou GB
    Cancer Lett; 2012 Sep; 322(2):185-94. PubMed ID: 22410463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
    Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.
    Chen C; Tang Y; Deng W; Huang C; Wu T
    Mol Med Rep; 2014 Aug; 10(2):917-22. PubMed ID: 24840151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
    Peng G; Cao RB; Li YH; Zou ZW; Huang J; Ding Q
    Mol Med Rep; 2014 Oct; 10(4):1709-16. PubMed ID: 25109634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients.
    Quintayo MA; Munro AF; Thomas J; Kunkler IH; Jack W; Kerr GR; Dixon JM; Chetty U; Bartlett JM
    Breast Cancer Res Treat; 2012 Nov; 136(1):161-8. PubMed ID: 22976805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F; Sasaguri T
    Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
    Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
    Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omethoate induces pharyngeal cancer cell proliferation and G1/S cell cycle progression by activation of Akt/GSK-3β/cyclin D1 signaling pathway.
    Huo D; Jiang S; Qin Z; Feng Y; Yang R; Lv L; Li Y
    Toxicology; 2019 Nov; 427():152298. PubMed ID: 31574243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.